Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 923860 | ISIN: FR0000073298 | Ticker-Symbol: IPZ
Tradegate
21.11.24
11:08 Uhr
44,280 Euro
-0,280
-0,63 %
1-Jahres-Chart
IPSOS SA Chart 1 Jahr
5-Tage-Chart
IPSOS SA 5-Tage-Chart
RealtimeGeldBriefZeit
44,22044,24013:04
44,20044,24013:04
PR Newswire
363 Leser
Artikel bewerten:
(2)

Essilor: New Ipsos global survey shines a light on the myopia epidemic

Finanznachrichten News

Revealing an urgency for long-term myopia management

LONDON, Nov. 12, 2024 /PRNewswire/ -- A new Ipsos survey[1] commissioned by Essilor® Stellest® lenses amongst 1,000 UK parents has revealed a serious lack of understanding around myopia in children. Indeed, 94% of parents of myopic children wrongly believe that wearing glasses will solve the problem.

Stellest Ipsos Logo

Myopia, or short-sightedness, is predicted to impact half of the World's population and a staggering one billion people are predicted to have high myopia by 2050[2].

Higher degrees of myopia pose a greater risk of ocular complications that may lead to visual impairment or even blindness later in life. However, the earlier myopia is detected and managed in a child, the greater the chance progression can be slowed down with simple lifestyle changes and by wearing special myopia control glasses or contact lenses available from your local optician.

The poll highlighted huge gaps in knowledge amongst parents around myopia:

  • The vast majority of parents of myopic children (94%) wrongly believe that having their myopic child wear glasses or contact lenses solves the problem.
  • Half (54%) of the parents questioned, including those without myopic children, were unaware that "the earlier myopia starts, the faster it progresses and the more serious it can become."
  • And almost half (48%) of all parents were aware that very short-sighted people have an increased risk of sight threatening eye complications, with the same amount (48%) unaware that myopia is progressing faster today than in previous generations.
  • Of the factors that may be associated with myopia, 56% of all parents did not know that lack of exposure to natural light was one of them.
  • In fact, almost two thirds of all parents (61%) admitted to finding it increasingly difficult to know exactly what to do to ensure that their child is and remains in good health.

Charlotte Timbury, Dispensing Optician and Director of Medical & Professional Affairs for EssilorLuxottica North Europe said: "Myopia, or short-sightedness, is when a child can see close up objects but struggles to see objects far away clearly, such as the whiteboard at school. This typically develops in children of school age and the younger a child becomes myopic, the more likely they will develop higher levels of myopia[3].

"It's evident that many parents and even those whose children are myopic, lack accurate information about myopia. Worryingly, many think that simply making their child wear glasses with corrective lenses solves the problem, unaware that myopia can progress even with corrective lenses.

"However, there are ways to slow it down with lifestyle changes and wearing a myopia control spectacle lens, such as Essilor Stellest lenses, which will correct myopia and slow down its progression."

More than correction: There is an urgency for long-term myopia management

The survey reveals that the majority of parents take a short-term view of myopia management, focusing on immediate compensation for the problem, overlooking the importance of follow-ups once the correction is in place and the existence of solutions to slow down the progression.

  • After correction, 69% of parents of myopic children are no longer really worried about their child's eyesight.
  • 78% of parents of myopic children even consider that they have done all they can and that there is not much left to do.
  • 79% of parents of myopic children wrongly believe that their child's myopia is likely to improve.
  • More than two thirds (69%) of parents of myopic children consider that their child's myopia will probably disappear in the next few years.
  • Overall, a third (32%) of parents are not aware that adopting appropriate habits such as taking a break when focusing on close objects for long periods and spending time outdoors could be beneficial in slowing down the onset of myopia.
  • And three quarters (76%) have not heard about spectacle lenses to slow down the progression of myopia.

Charlotte continues: "Myopia must be addressed and managed as soon as possible in childhood, and thankfully, recent developments in myopia control spectacle lenses can help this. Essilor Stellest lenses are safe and easy to wear and enable the child to continue to wear their spectacles without any compromise. In fact, over a 5-year period, myopia progression was two times slower on average with Essilor Stellest lenses*[4].

"This, combined with some simple lifestyle changes can help reduce the risk of high myopia and its potentially associated complications once the child reaches adulthood.

"Getting outside as much as possible and keeping leisure screen time outside of schoolwork to a minimum has been shown to help delay the onset of myopia. Myopia can progress rapidly so it's important to know the signs to watch out for such as sitting too close to the TV and difficulty seeing the board at school, and for children to keep up with their regular eye examination once a year."

About Essilor® Stellest®

Essilor® Stellest® lenses are Essilor®'s best solution for fighting myopia in children because they have two functions. First, they correct myopia, giving the wearer sharp vision. And second, they slow down its progression by positioning a volume of non-focused light in front of the retina, following the retina's shape which sends a signal to slow down eye elongation.

Essilor® Stellest® lenses slow down the progression of myopia by 67% on average, compared to single vision lenses, when worn 12 hours per day**[5].

Visit https://www.essilor.com/uk-en/products/stellest/.

About Essilor®:

Essilor®, part of EssilorLuxottica's portfolio, is a leader in eyeglass lenses worldwide[6] and the number one lens brand recommended by eye care professionals (ECP)[7]. It offers a complete range of solutions dedicated to each individual's vision and lifestyle needs throughout their life. Every Essilor® lens is a combination of multiple complementary technologies thanks to its suite of leading premium vision care solutions, including innovative brands such as Stellest®, Eyezen® and Varilux® and Crizal®. These groundbreaking technologies correct vision, protect eyes from UV rays and enhance visual clarity.

REFERENCES:

1. International survey conducted by Ipsos in 6 countries on 6007 parents with at least one child aged from 5 to 17, from a representative sample of individuals aged from 25 to 60 in terms of age, gender, occupation, region. UK: 1000 interviews / Italy: 1001 interviews / France: 1000 interviews / Brazil: 1001 interviews / India: 1005 interviews / China: 1000 interviews. Online interviews from June 24th to July 15th 2024.
2. Source: Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006.
3. Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading? Ophthal Physiol Opt 2020;40:254-270.
4. Li X, Huang Y, Liu C, Yin Z, Cui Z, Lim EW, Drobe B, Chen H, Bao J. Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a 5-year follow-up study. Presented at the Association for Research in Vision and Ophthalmology (ARVO)Annual Meeting, Seattle, 2024.
5. Bao, J., Huang, Y., Li, X., Yang, A., Zhou, F., Wu, J., Wang, C., Li, Y., Lim, E.W., Spiegel, D.P., Drobe, B. and Chen, H., 2022. "Spectacle Lenses with Aspherical Lenslets for Myopia Control vs Single Vision Spectacle Lenses: A Randomized Clinical Trial." JAMA Ophthalmol. 1 40(5), 472 - 478. https://doi.org/10.1001/jamaophthalmol.2022.0401.
6. Source: Euromonitor, Eyewear 2023 edition; Essilor International company; worldwide retail value sales at RSP.
7. Quantitative research conducted among a representative sample of 958 independent ECPs by CSA in February 2019 - France, the UK, Germany, Italy, Spain, the US, Canada, Brazil, China, India.

DISCLAIMERS:

*Compared to the 60-month progression of the extrapolated control group (predicted average annual decrease in SER by 9.7% based on the initial 2-year control group, Smotherman C, et al. IOVS 2023;64:ARVO E-Abstract 811).
**Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor® Stellest® lenses compared to 50 myopic children wearing single vision lenses in Wenzhou China. Results based on 32 children from the Test Group wearing Essilor® Stellest® lenses at least 12 hours per day every day for two consecutive years.

Logo: https://mma.prnewswire.com/media/2554387/Stellest_Ipsos_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/new-ipsos-global-survey-shines-a-light-on-the-myopia-epidemic-302302559.html

© 2024 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.